Pain News and Research

Latest Pain News and Research

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Study: Sleep apnea common among survivors of acute respiratory failure

Study: Sleep apnea common among survivors of acute respiratory failure

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

Bristol-Myers Squibb reports updated survival data from Phase 1b study of advanced melanoma

State highlights: 700 nurses needed for health care help in Calif. county; Missouri abortion wait period; nursing home funding in Maine

State highlights: 700 nurses needed for health care help in Calif. county; Missouri abortion wait period; nursing home funding in Maine

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

Anticoagulation therapy with low-dose aspirin can be used with new generation mechanical heart valve

New tech could take light-based cancer treatment deep inside the body

New tech could take light-based cancer treatment deep inside the body

VHI publishes hospital patient satisfaction information on website

VHI publishes hospital patient satisfaction information on website

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Depression is the leading cause of illness in adolescents, shows WHO's report

Depression is the leading cause of illness in adolescents, shows WHO's report

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

Two new Manchester research centres aim at improving lives of people with arthritis

Two new Manchester research centres aim at improving lives of people with arthritis

Tips to prevent sunburn and reduce risk of skin cancer

Tips to prevent sunburn and reduce risk of skin cancer

UNF Professor discovers 2 Lyme disease bacterial species that infect human patients

UNF Professor discovers 2 Lyme disease bacterial species that infect human patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.